PharmAla Biotech Holdings, Inc.'s total assets for Q2 2025 were C$3.91M, an increase of 48.60% from the previous quarter. TSE:MDMA total liabilities were C$812.25K for the fiscal quarter, a 12.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.